$20m-$39.9m

Celgene and Evotec have put capital into Exscientia as the Dundee-founded automated drug discovery services provider added Roche to its roster of development partners.

Lidar technology developer Baraja has lured the support of Csiro's Innovation Fund as it pursues additional business for its autonomous vehicle perception system in the US and Asia.

Based on Oxford and Sao Paulo State University research, Osler Diagnostics is reportedly set to secure $38m to add to the $2.6m it raised in 2016.

Pulmonary arterial hypertension therapy business Morphogen-IX has been backed by Cambridge Enterprise and Cambridge Innovation Capital in a $23.3m round.

Agilent and Lam Research participated in a $30m series B for UCSF's DNA analysis spinout Mission Bio, whose existing shareholders include Stanford-StartX Fund.

UTokyo Innovation Platform has backed a $22.8m investment round for Axelspace that will fund the launch of the Tokyo spinout's latest satellite.

Tel Aviv University announces $20m commercialisation fund with Tata Industries.

Invesco Perpetual, the fund manager, and Imperial Innovations, the London Stock Exchange-listed spin-off from Imperial College London, are joined by The Cancer Prevention and Research Institute of Texas and the Wellcome Trust supporting Cell Medica's growth.

Revolymer, which makes chewing gum that is easier to remove from streets and pavements, was backed by the Setsquared Partnership, a joint venture capital initiative between Bath, Bristol, Exeter, Southampton and Surrey.